1![A Clinical Development CompanyForm 10-K
EntreMed, Inc. (Nasdaq: ENMD) is a clinical-stage pharmaceutical company focused on developing A Clinical Development CompanyForm 10-K
EntreMed, Inc. (Nasdaq: ENMD) is a clinical-stage pharmaceutical company focused on developing](https://www.pdfsearch.io/img/34c8673a4022b5b8262b5332be58ef5f.jpg) | Add to Reading ListSource URL: www.casipharmaceuticals.comLanguage: English - Date: 2014-05-14 13:07:09
|
---|
2![Preliminary Programme Cell Cycle Regulators/Inhibitors and Cancer February 5-8, 2011, Vienna Austria Saturday, February – 18.00 Preliminary Programme Cell Cycle Regulators/Inhibitors and Cancer February 5-8, 2011, Vienna Austria Saturday, February – 18.00](https://www.pdfsearch.io/img/57447d1300f150683aa056a01856b895.jpg) | Add to Reading ListSource URL: viscea.orgLanguage: English - Date: 2014-07-18 02:56:43
|
---|
3![Product Name: Additive T Category: Aluminum Brightening Order Code: ADDT METAL FINISHING PRODUCTS Source: Aurora, NC Alternate Names: Transfer Etch Inhibitor Product Name: Additive T Category: Aluminum Brightening Order Code: ADDT METAL FINISHING PRODUCTS Source: Aurora, NC Alternate Names: Transfer Etch Inhibitor](https://www.pdfsearch.io/img/938a73df6452ff3989ca962eb6a35268.jpg) | Add to Reading ListSource URL: www.potashcorp.comLanguage: English - Date: 2011-11-22 15:29:27
|
---|
4![Encouraging Data on Astex’s Anti-Cancer Drug AT9283 to be Presented at ASH New Data Suggest a Potential Role for AT9283 in Combination With Lenalidomide and With Docetaxel in the Treatment of Multiple Myeloma and Non-H Encouraging Data on Astex’s Anti-Cancer Drug AT9283 to be Presented at ASH New Data Suggest a Potential Role for AT9283 in Combination With Lenalidomide and With Docetaxel in the Treatment of Multiple Myeloma and Non-H](https://www.pdfsearch.io/img/764474d15896a37128b6df7f9154222f.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
5![Astex Pharmaceuticals to Present at AACR Annual Meeting DUBLIN, Calif., March 29, [removed]Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel small mole Astex Pharmaceuticals to Present at AACR Annual Meeting DUBLIN, Calif., March 29, [removed]Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel small mole](https://www.pdfsearch.io/img/5b02d80f7ad8cb25e09fef2ec7c56d10.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
6![Mitosis-targeted anti-cancer therapies: where they stand Mitosis-targeted anti-cancer therapies: where they stand](https://www.pdfsearch.io/img/a8f74be91e1cf52840a926aaf6ea10f4.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2012-10-18 05:59:12
|
---|
7![V Contents List of Contributors XI Preface XV A Personal Foreword XVII V Contents List of Contributors XI Preface XV A Personal Foreword XVII](https://www.pdfsearch.io/img/4285448710e8423af8f51bc44f8c015e.jpg) | Add to Reading ListSource URL: www.wiley-vch.deLanguage: English - Date: 2011-03-20 22:04:20
|
---|
8![j365 Index a A[removed]A[removed] j365 Index a A[removed]A[removed]](https://www.pdfsearch.io/img/118fff919038838bc4c412695a7820f0.jpg) | Add to Reading ListSource URL: www.wiley-vch.deLanguage: English - Date: 2011-03-20 22:04:26
|
---|
9![Biology 2014, 3, [removed]; doi:[removed]biology3010167 OPEN ACCESS Biology 2014, 3, [removed]; doi:[removed]biology3010167 OPEN ACCESS](https://www.pdfsearch.io/img/a414b171fe1c9e60d8a07f351c2968a4.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|